Case Studies
Rare Pain Condition Gets Rare FDA Reprieve: Saved Valuable Time and $$$
Challenge: A biotech developing a therapy for a rare metabolic bone disease faced regulatory misalignment with FDA pain guidelines, risking costly dual Phase 3 trials. What We did: Efficus Health crafted an alternative regulatory pathway, engaged directly with...
Driving Credibility: A Comprehensive Publication Strategy for a Medical Device Startup
Challenge: A biotech developing a high-cost, one-time gene therapy lacked expertise to navigate payer models and reimbursement challenges. What Efficus Health did: Conducted payer research, developed a defensible pricing strategy, and built a roadmap for access and...
De-risking Market Access: A Strategic Pricing and Payer Blueprint for a Gene Therapy
Challenge: A biotech developing a high-cost, one-time gene therapy lacked expertise to navigate payer models and reimbursement challenges. What Efficus Health did: Conducted payer research, developed a defensible pricing strategy, and built a roadmap for access and...
Beyond the Protocol: Designing Patient-Centric Clinical Trials with Cross-Functional Input
Challenge: A biotech designing a pivotal trial sought to reduce patient burden and improve recruitment while aligning with payer and market needs. What Efficus Health did: Integrated patient insights, advocacy feedback, and cross-functional expertise (Medical...
Navigating the First Launch: Efficus Health’s Strategic Medical Affairs Blueprint
Challenge : A small biotech preparing for its first launch needed a Medical Affairs strategy to shift from R&D focus to commercial readiness. What Efficus Health did: Conducted landscape analysis, designed a scientific narrative, planned evidence...




